{"a":[{"_":"Replimune secures FDA approval for melanoma therapy Tudriqev after long regulatory battle","$":{"href":"/pharma/replimune-secures-fda-approval-melanoma-therapy-tudriqev-after-long-regulatory-battle","hreflang":"en"}}]}
RegulatoryapprovedTudriqevPositive
AI Analysis
Summary
Replimune secured FDA approval for Tudriqev, its melanoma therapy, after two prior rejections and regulatory challenges. The approval represents a significant regulatory turnaround for the company.
Outcome Details
FDA approval after two prior rejections
Importance:9/10
Sentiment:
0.85
FDA approvalmelanomaregulatory turnaroundresubmission success
Related Companies
Read the original article
Published by FiercePharma on August 6, 2026 4:48 PM